TONGHUA DONGBAO PHARMACEUTICAL

tonghua-dongbao-pharmaceutical-logo

Tonghua Dongbao Pharma develops and markets recombinant human insulin for the treatment of diabetes.

#Financial #More

TONGHUA DONGBAO PHARMACEUTICAL

Social Links:

Industry:
Biotechnology Pharmaceutical

Founded:
1985-01-01

Status:
Active

Total Funding:
283 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Apache Mobile Non Scaleable Content Euro DigiCert SSL Pound Sterling Japanese Yen


Stock Details


Company's stock symbol is SSE:600867

Investors List

dcp-capital_image

DCP Capital

DCP Capital investment in Post-IPO Equity - Tonghua Dongbao Pharmaceutical

Investments List

Date Company Article Money raised
2017-04-14 POCTech Corporation Tonghua Dongbao Pharmaceutical investment in Series B - POCTech Corporation 100 M CNY
2015-12-28 AMOYTOP BIOTECH Tonghua Dongbao Pharmaceutical investment in Funding Round - AMOYTOP BIOTECH 50 M CNY

More informations about "Tonghua Dongbao Pharmaceutical"

linkstock.net © 2022. All rights reserved